CBAY
Cymabay Therapeutics
CBAY
CBAY
Delisted
CBAY was delisted on the 21st of March, 2024.
113 hedge funds and large institutions have $227M invested in Cymabay Therapeutics in 2021 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 26 increasing their positions, 41 reducing their positions, and 29 closing their positions.
Holders
113
Holders Change
-17
Holders Change %
-13.08%
% of All Funds
1.97%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
12
Increased
26
Reduced
41
Closed
29
Calls
$2.1M
Puts
$3.45M
Net Calls
-$1.35M
Net Calls Change
+$779K
Top Buyers
| 1 |
CC
1
Commodore Capital
New York
|
$15.4M |
| 2 |
KPWS
2
Kestra Private Wealth Services
Austin,
Texas
|
$2.18M |
| 3 |
3
Norges Bank
Oslo,
Norway
|
$2.02M |
| 4 |
4
Morgan Stanley
New York
|
$2.21M |
| 5 |
DCM
5
DAFNA Capital Management
Los Angeles,
California
|
$2.23M |
Top Sellers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$1.54M |
| 2 |
2
Two Sigma Investments
New York
|
$1.18M |
| 3 |
3
BlackRock
New York
|
$23.7M |
| 4 |
4
Two Sigma Advisers
New York
|
$3.7M |
| 5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$14.5M |
